help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on March 1, 2007, doi:10.1164/rccm.200608-1113OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200608-1113OCv1
175/10/998    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demedts, I. K.
Right arrow Articles by Brusselle, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demedts, I. K.
Right arrow Articles by Brusselle, G. G.
American Journal of Respiratory and Critical Care Medicine Vol 175. pp. 998-1005, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200608-1113OC

Original Article

Accumulation of Dendritic Cells and Increased CCL20 Levels in the Airways of Patients with Chronic Obstructive Pulmonary Disease

Ingel K. Demedts1, Ken R. Bracke1, Geert Van Pottelberge1, Dries Testelmans2, Geert M. Verleden2, Frank E. Vermassen3, Guy F. Joos1 and Guy G. Brusselle1

1 Department of Respiratory Diseases, Ghent University Hospital, Ghent; 2 Department of Respiratory Diseases, Leuven University Hospital, Leuven; and 3 Department of Thoracic and Vascular Surgery, Ghent University Hospital, Ghent, Belgium

Correspondence and requests for reprints should be addressed to Ingel K. Demedts, Department of Respiratory Diseases, Ghent University Hospital 7K12IE, De Pintelaan 185, B-9000 Ghent, Belgium. E-mail M.DemedtsIngelK{at}UGent.be

Rationale: Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation. It is unclear if dendritic cells (DC) participate in this inflammatory process.

Objectives: To evaluate the presence of DC in small airways of patients with COPD.

Methods: We evaluated DC infiltration in small airways by immunohistochemistry in patients with COPD (stage I-IV), never-smokers, and smokers without COPD. Chemokine ligand 20 (CCL20, the most potent chemokine in attracting DC) was determined in total lung by RT-PCR and in induced sputum by enzyme-linked immunsorbent assay. Chemokine receptor 6 (CCR6, the receptor for CCL20) expression on human pulmonary DC was evaluated by RT-PCR and flow cytometry.

Measurements and Main Results: There is a significant increase in DC number in the epithelium (p = 0.007) and adventitia (p = 0.009) of small airways of patients with COPD compared with never-smokers and smokers without COPD. DC number in epithelium and adventitia increases along with disease severity. CCL20 mRNA expression in total lung and CCL20 protein levels in induced sputum are significantly higher in patients with COPD compared with never-smokers (p = 0.034 for CCL20 mRNA and p = 0.0008 for CCL20 protein) and smokers without COPD (p = 0.016 for CCL20 mRNA and p = 0.001 for CCL20 protein). DC isolated from human lung express CCR6 both at mRNA and at protein level.

Conclusions: This is the first description of airway infiltration by DC in COPD. Moreover, interaction between CCL20 and CCR6 provides a possible mechanism for accumulation of DC in the lungs in COPD.

Key Words: langerin • CCL20 • CCR6


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation. Macrophages, neutrophils, and CD8+ T cells participate in this inflammatory process. It is unclear if dendritic cells (DC) are involved in the chronic airway inflammation in COPD.

What This Study Adds to the Field
There is accumulation of DC in COPD airways, which increases with disease severity. It is demonstrated that CCL20 (the most important chemokine for attracting DC) is elevated in COPD lungs and DC express CCR6 (receptor for CCL20).

 



This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. A. Poole, G. M. Thiele, N. E. Alexis, A. M. Burrell, C. Parks, and D. J. Romberger
Organic dust exposure alters monocyte-derived dendritic cell differentiation and maturation
Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L767 - L776.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Tsoumakidou, A. V. Koutsopoulos, N. Tzanakis, K. Dambaki, E. Tzortzaki, S. Zakynthinos, P. K. Jeffery, and N. M. Siafakas
Decreased Small Airway and Alveolar CD83+ Dendritic Cells in COPD
Chest, September 1, 2009; 136(3): 726 - 733.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. G. Tzortzaki and N. M. Siafakas
A hypothesis for the initiation of COPD
Eur. Respir. J., August 1, 2009; 34(2): 310 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
G. G. Brusselle, T. Demoor, K. R. Bracke, C-A. Brandsma, and W. Timens
Lymphoid follicles in (very) severe COPD: beneficial or harmful?
Eur. Respir. J., July 1, 2009; 34(1): 219 - 230.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. G. Cosio, M. Saetta, and A. Agusti
Immunologic Aspects of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., June 4, 2009; 360(23): 2445 - 2454.
[Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
B. D. Medoff, A. L. Landry, K. A. Wittbold, B. P. Sandall, M. C. Derby, Z. Cao, J. C. Adams, and R. J. Xavier
CARMA3 Mediates Lysophosphatidic Acid-Stimulated Cytokine Secretion by Bronchial Epithelial Cells
Am. J. Respir. Cell Mol. Biol., March 1, 2009; 40(3): 286 - 294.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. J. Carlson, M. L. West, J. M. Coghill, A. Panoskaltsis-Mortari, B. R. Blazar, and J. S. Serody
In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations
Blood, February 5, 2009; 113(6): 1365 - 1374.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. M. Kent, L. J. C. Smyth, J. Plumb, C. L. Clayton, S. M. Fox, D. W. Ray, S. N. Farrow, and D. Singh
Inhibition of Lipopolysaccharide-Stimulated Chronic Obstructive Pulmonary Disease Macrophage Inflammatory Gene Expression by Dexamethasone and the p38 Mitogen-Activated Protein Kinase Inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504)
J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 458 - 468.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. G. McComb, M. Ranganathan, X. H. Liu, J. M. Pilewski, P. Ray, S. C. Watkins, A. M.K. Choi, and J. S. Lee
CX3CL1 Up-Regulation Is Associated with Recruitment of CX3CR1+ Mononuclear Phagocytes and T Lymphocytes in the Lungs during Cigarette Smoke-Induced Emphysema
Am. J. Pathol., October 1, 2008; 173(4): 949 - 961.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
K. F. Chung and I. M. Adcock
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
K. Bratke, M. Klug, A. Bier, P. Julius, M. Kuepper, J. C. Virchow, and M. Lommatzsch
Function-Associated Surface Molecules on Airway Dendritic Cells in Cigarette Smokers
Am. J. Respir. Cell Mol. Biol., June 1, 2008; 38(6): 655 - 660.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Tsoumakidou, I. K. Demedts, G. G. Brusselle, and P. K. Jeffery
Dendritic Cells in Chronic Obstructive Pulmonary Disease: New Players in an Old Game
Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1180 - 1186.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A V Rogers, E Adelroth, K Hattotuwa, A Dewar, and P K Jeffery
Bronchial mucosal dendritic cells in smokers and ex-smokers with COPD: an electron microscopic study
Thorax, February 1, 2008; 63(2): 108 - 114.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
E. F. M. Wouters, K. H. Groenewegen, M. A. Dentener, and J. H. J. Vernooy
Systemic Inflammation in Chronic Obstructive Pulmonary Disease: The Role of Exacerbations
Proceedings of the ATS, December 1, 2007; 4(8): 626 - 634.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. Marchal-Somme, Y. Uzunhan, S. Marchand-Adam, M. Kambouchner, D. Valeyre, B. Crestani, and P. Soler
Dendritic Cells Accumulate in Human Fibrotic Interstitial Lung Disease
Am. J. Respir. Crit. Care Med., November 15, 2007; 176(10): 1007 - 1014.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
I. K. Demedts, G. F. Joos, and G. G. Brusselle
Pulmonary dendritic cells: playing ball in the BAL?
Eur. Respir. J., November 1, 2007; 30(5): 823 - 824.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Lommatzsch, K. Bratke, A. Bier, P. Julius, M. Kuepper, W. Luttmann, and J. C. Virchow
Airway dendritic cell phenotypes in inflammatory diseases of the human lung
Eur. Respir. J., November 1, 2007; 30(5): 878 - 886.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Tsoumakidou and P. K. Jeffery
Dendritic Cell Maturity and Obstructive Airway Disease
Am. J. Respir. Crit. Care Med., October 15, 2007; 176(8): 833 - 833.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
I. K. Demedts, G. F. Joos, and G. G. Brusselle
Dendritic Cell Maturity and Obstructive Airway Disease
Am. J. Respir. Crit. Care Med., October 15, 2007; 176(8): 833 - 834.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society